The Indianapolis Business Journal’s John Russell is reporting that Indiana life sciences companies raised $115 million in venture capital funding in 2018, a three percent jump from 2017 and 133 percent higher than 2015.
“The thing that jumped out at me was the variety,” said Brian Stemme, who tracks venture deals for BioCrossroads (CICP’s life sciences initiative), pointing to products under development ranging from cancer drugs to tele-health software. [READ MORE]
(Sources: IBJ and BioCrossroads)
